Does FDA’s elimination of the #clozapine #REMS requirements have you wondering what to do next? Join us for a webinar this Wednesday at noon ET, when we’ll discuss the implications of FDA’s momentous decision. Our panel of experts will talk about what pharmacies, prescribers and insurance companies can do to help make clozapine accessible to the people who need it – and what people with #schizophrenia can do in the meantime. Register now to secure your spot: https://bit.ly/4i1Scd5
